製品名
Phospho-Lamin A + Lamin C (S22) Recombinant Rabbit Monoclonal Antibody [PSH11-48] - BSA and Azide free
抗体のタイプ
Recombinant Rabbit monoclonal Antibody
免疫原
Synthetic phospho-peptide corresponding to residues surrounding Ser22 of Human Lamin A + Lamin C.
標的分子量
Predicted band size: 74 kDa
ポジティブコントロール
HeLa cell lysate, HeLa treated with 100nM paclitaxel for 20 hours cell lysate, NIH/3T3 cell lysate, NIH/3T3 treated with 100nM paclitaxel for 20 hours cell lysate, C6 cell lysate, C6 treated with 4mM hydroxyurea for 20 hours cell lysate.
保存方法
Store at 2-8℃. Avoid freeze.
精製方法
Protein A affinity purified.
機能
Prelamin-A/C, or lamin A/C is a protein that in humans is encoded by the LMNA gene. Lamin A/C belongs to the lamin family of proteins. DNA double-strand damages can be repaired by either homologous recombination (HR) or non-homologous end joining (NHEJ). LMNA promotes genetic stability by maintaining the levels of proteins that have key roles in HR and NHEJ. Mouse cells that are deficient for maturation of prelamin A have increased DNA damage and chromosome aberrations, and show increased sensitivity to DNA damaging agents. In progeria, the inadequacy of DNA repair, due to defective LMNA, may cause features of premature aging (see DNA damage theory of aging).
背景・参考文献
1. Kovacs MT et. al. DNA damage induces nuclear envelope rupture through ATR-mediated phosphorylation of lamin A/C. Mol Cell. 2023 Oct
2. Yamada S et al. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy. Sci Adv. 2023 Apr
サブセルラー局在
Nucleus lamina, Nucleus envelope, nucleoplasm, Nucleus matrix; Nucleus speckle.
別名
70 kDa lamin antibody
Cardiomyopathy dilated 1A (autosomal dominant) antibody
CDCD1 antibody
CDDC antibody
CMD1A antibody
CMT2B1 antibody
EMD2 antibody
FPL antibody
FPLD antibody
FPLD2 antibody
詳細を見る
70 kDa lamin antibody
Cardiomyopathy dilated 1A (autosomal dominant) antibody
CDCD1 antibody
CDDC antibody
CMD1A antibody
CMT2B1 antibody
EMD2 antibody
FPL antibody
FPLD antibody
FPLD2 antibody
HGPS antibody
IDC antibody
Lamin A antibody
Lamin A/C antibody
Lamin A/C like 1 antibody
Lamin antibody
Lamin C antibody
Lamin-A/C antibody
LDP1 antibody
LFP antibody
LGMD1B antibody
Limb girdle muscular dystrophy 1B (autosomal dominant) antibody
LMN 1 antibody
LMN A antibody
LMN C antibody
LMN1 antibody
LMNA antibody
LMNA_HUMAN antibody
LMNC antibody
LMNL1 antibody
Prelamin A/C antibody
PRO1 antibody
Renal carcinoma antigen NY REN 32 antibody
Renal carcinoma antigen NY-REN-32 antibody
Renal carcinoma antigen NYREN32 antibody
閉じる
-
☑ Cell treatment (CT)
This data was developed using HA723340, the same antibody clone in a different buffer formulation.
Western blot analysis of Phospho-Lamin A + Lamin C (S22) on different lysates with Rabbit anti-Phospho-Lamin A + Lamin C (S22) antibody (HA723340) at 1/2,000 dilution and pan Lamin A + Lamin C antibody (ET7110-12) at 1/2,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: HeLa treated with 100nM paclitaxel for 20 hours cell lysate
Lane 3: NIH/3T3 cell lysate
Lane 4: NIH/3T3 treated with 100nM paclitaxel for 20 hours cell lysate
Lane 5: C6 cell lysate
Lane 6: C6 treated with 4mM hydroxyurea for 20 hours cell lysate
Lane 7: HeLa treated with 100nM paclitaxel for 20 hours cell lysate, then the membrane treated with λpp for 1 hour
Lane 8: NIH/3T3 treated with 100nM paclitaxel for 20 hours cell lysate, then the membrane treated with λpp for 1 hour
Lane 9: C6 treated with 4mM hydroxyurea for 20 hours cell lysate, then the membrane treated with λpp for 1 hour
Lysates/proteins at 20 µg/Lane.
Predicted band size: 74 kDa
Observed band size: 70/65 kDa
Exposure time: 4 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723340) at 1/2,000 dilution and pan Lamin A + Lamin C antibody (ET7110-12) at 1/2,000 dilution were used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
ご注意: 本製品はすべて「研究用試薬」です。人や動物の診断・治療目的、または臨床診断には使用できません。(FOR RESEARCH USE ONLY)